HomeCompareXPHYF vs KMB

XPHYF vs KMB: Dividend Comparison 2026

XPHYF yields 705.11% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XPHYF wins by $964927.33M in total portfolio value
10 years
XPHYF
XPHYF
● Live price
705.11%
Share price
$0.28
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$964927.37M
Annual income
$754,446,983,210.15
Full XPHYF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — XPHYF vs KMB

📍 XPHYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXPHYFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XPHYF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XPHYF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XPHYF
Annual income on $10K today (after 15% tax)
$59,934.07/yr
After 10yr DRIP, annual income (after tax)
$641,279,935,728.63/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, XPHYF beats the other by $641,279,931,299.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XPHYF + KMB for your $10,000?

XPHYF: 50%KMB: 50%
100% KMB50/50100% XPHYF
Portfolio after 10yr
$482463.71M
Annual income
$377,223,494,210.73/yr
Blended yield
78.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

XPHYF
No analyst data
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XPHYF buys
0
KMB buys
0
No recent congressional trades found for XPHYF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXPHYFKMB
Forward yield705.11%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$964927.37M$45.9K
Annual income after 10y$754,446,983,210.15$5,211.33
Total dividends collected$947907.97M$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: XPHYF vs KMB ($10,000, DRIP)

YearXPHYF PortfolioXPHYF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$81,211$70,510.67$11,314$613.68+$69.9KXPHYF
2$622,056$535,160.68$12,865$759.19+$609.2KXPHYF
3$4,496,642$3,831,041.55$14,709$943.96+$4.48MXPHYF
4$30,693,047$25,881,640.63$16,919$1,180.17+$30.68MXPHYF
5$197,946,383$165,104,822.52$19,588$1,484.33+$197.93MXPHYF
6$1,206,941,168$995,138,538.05$22,838$1,879.06+$1206.92MXPHYF
7$6,962,148,280$5,670,721,230.88$26,832$2,395.60+$6962.12MXPHYF
8$38,020,642,481$30,571,143,821.30$31,788$3,077.63+$38020.61MXPHYF
9$196,710,644,881$156,028,557,426.06$38,000$3,986.82+$196710.61MXPHYF
10$964,927,373,233$754,446,983,210.15$45,872$5,211.33+$964927.33MXPHYF

XPHYF vs KMB: Complete Analysis 2026

XPHYFStock

BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, thin film drug formulation, and psychedelic pharmaceutical production and formulation businesses. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Full XPHYF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this XPHYF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XPHYF vs SCHDXPHYF vs JEPIXPHYF vs OXPHYF vs KOXPHYF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.